Package 70518-2276-0

{"route": ["ORAL"], "spl_id": "49f0ac09-d5f1-4bc2-e063-6294a90a8319", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["312137"], "spl_set_id": ["6d2a6cac-f16b-4e6c-8f75-3afffb0a0f3b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2276-0)", "package_ndc": "70518-2276-0", "marketing_start_date": "20190822"}], "brand_name": "OXCARBAZEPINE", "product_id": "70518-2276_49f0ac09-d5f1-4bc2-e063-6294a90a8319", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-2276", "generic_name": "OXCARBAZEPINE", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/1"}], "application_number": "ANDA078069", "marketing_category": "ANDA", "marketing_start_date": "20190822", "listing_expiration_date": "20271231"}